Variable | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
HR | 95% CI | P | HR | 95% CI | P | |
Age (years) | ||||||
≤ 60 | Reference | |||||
> 60 | 2.074 | 0.721–5.966 | 0.176 | |||
Gender | ||||||
Female | Reference | |||||
Male | 1.064 | 0.385–2.939 | 0.905 | |||
Tumor size (cm) | ||||||
≤ 2.5 | Reference | Reference | ||||
> 2.5 | 7.336 | 1.655–32.514 | 0.009 | NA | NA | 0.249 |
Symptoms | ||||||
Absent | Reference | |||||
Present | 3.223 | 0.727–14.292 | 0.123 | |||
PD-NLR | ||||||
0 | Reference | Reference | ||||
1 | 20.055 | 2.444–164.556 | 0.005 | 16.159 | 1.902–137.304 | 0.011 |
2 | 56.819 | 6.874–469.680 | < 0.001 | 32.737 | 3.561–300.966 | 0.002 |
Type of hormone production | ||||||
Functioning | Reference | |||||
Non-functioning | 33.418 | 0.265–4211.462 | 0.155 | |||
T-stage | ||||||
T1–2 | Reference | Reference | ||||
T3–4 | 3.602 | 1.303–9.953 | 0.013 | NA | NA | 0.567 |
LN metastasis | ||||||
Absent | Reference | Reference | ||||
Present | 6.896 | 2.359–20.157 | < 0.001 | NA | NA | 0.608 |
Distant metastasis | ||||||
Absent | Reference | |||||
Present | 3.438 | 0.426–27.722 | 0.246 | |||
Perineural invasion | ||||||
Absent | Reference | Reference | ||||
Present | 6.453 | 2.247–18.537 | 0.001 | NA | NA | 0.118 |
WHO classification | ||||||
Grade 1–2 | Reference | Reference | ||||
Grade 3 | 19.191 | 4.735–77.784 | < 0.001 | 5.222 | 1.227–22.218 | 0.025 |